Genetic silencing of MEOX2 and GLI-1 in NSCLC cells revealed significant changes in EGFR, CBP and SMARCB1 protein levels, indicating the potential regulatory roles of MEOX2/GLI-1 in accordance with preceding studies [8]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.